CD163 and ovarian cancer: Initial studies characterizing TAMs in ovarian cancer demonstrate that TAMs most closely resemble M2-polarized macrophages and express M2 markers such as CD163, CD204, CD206 (Mannose Receptor), and IL-10 (23–26).